110 related articles for article (PubMed ID: 32015453)
1. Rational design of small molecule RHOA inhibitors for gastric cancer.
Kim JH; Park S; Lim SM; Eom HJ; Balch C; Lee J; Kim GJ; Jeong JH; Nam S; Kim YH
Pharmacogenomics J; 2020 Aug; 20(4):601-612. PubMed ID: 32015453
[TBL] [Abstract][Full Text] [Related]
2. Systematic approach identifies RHOA as a potential biomarker therapeutic target for Asian gastric cancer.
Chang HR; Nam S; Lee J; Kim JH; Jung HR; Park HS; Park S; Ahn YZ; Huh I; Balch C; Ku JL; Powis G; Park T; Jeong JH; Kim YH
Oncotarget; 2016 Dec; 7(49):81435-81451. PubMed ID: 27806312
[TBL] [Abstract][Full Text] [Related]
3. Second-Generation JK-206 Targets the Oncogenic Signal Mediator RHOA in Gastric Cancer.
Beak M; Park S; Kim JH; Eom HJ; Lee HY; Kim YH; Lee J; Nam S
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406376
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy Resistance in Diffuse-Type Gastric Adenocarcinoma Is Mediated by RhoA Activation in Cancer Stem-Like Cells.
Yoon C; Cho SJ; Aksoy BA; Park DJ; Schultz N; Ryeom SW; Yoon SS
Clin Cancer Res; 2016 Feb; 22(4):971-83. PubMed ID: 26482039
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-31 inhibits tumor invasion and metastasis by targeting RhoA in human gastric cancer.
Ge F; Wang C; Wang W; Liu W; Wu B
Oncol Rep; 2017 Aug; 38(2):1133-1139. PubMed ID: 28656284
[TBL] [Abstract][Full Text] [Related]
6. Reversal of the malignant phenotype of gastric cancer cells by inhibition of RhoA expression and activity.
Liu N; Bi F; Pan Y; Sun L; Xue Y; Shi Y; Yao X; Zheng Y; Fan D
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6239-47. PubMed ID: 15448013
[TBL] [Abstract][Full Text] [Related]
7. Current Study of RhoA and Associated Signaling Pathways in Gastric Cancer.
Liu H; Liu Y; Zhang X; Wang X
Curr Stem Cell Res Ther; 2020; 15(7):607-613. PubMed ID: 32223738
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Rho-Associated Kinase 1/2 Attenuates Tumor Growth in Murine Gastric Cancer.
Hinsenkamp I; Schulz S; Roscher M; Suhr AM; Meyer B; Munteanu B; Fuchser J; Schoenberg SO; Ebert MP; Wängler B; Hopf C; Burgermeister E
Neoplasia; 2016 Aug; 18(8):500-11. PubMed ID: 27566106
[TBL] [Abstract][Full Text] [Related]
9. C5a receptor (CD88) promotes motility and invasiveness of gastric cancer by activating RhoA.
Kaida T; Nitta H; Kitano Y; Yamamura K; Arima K; Izumi D; Higashi T; Kurashige J; Imai K; Hayashi H; Iwatsuki M; Ishimoto T; Hashimoto D; Yamashita Y; Chikamoto A; Imanura T; Ishiko T; Beppu T; Baba H
Oncotarget; 2016 Dec; 7(51):84798-84809. PubMed ID: 27756879
[TBL] [Abstract][Full Text] [Related]
10. MiR-31 Regulates Rho-Associated Kinase-Myosin Light Chain (ROCK-MLC) Pathway and Inhibits Gastric Cancer Invasion: Roles of RhoA.
Chen Z; Liu S; Xia Y; Wu K
Med Sci Monit; 2016 Dec; 22():4679-4691. PubMed ID: 27904131
[TBL] [Abstract][Full Text] [Related]
11. Type II cGMP‑dependent protein kinase inhibits RhoA activation in gastric cancer cells.
Wang Y; Chen Y; Li Y; Lan T; Qian H
Mol Med Rep; 2014 Apr; 9(4):1444-52. PubMed ID: 24549567
[TBL] [Abstract][Full Text] [Related]
12. The in silico identification of small molecules for protein-protein interaction inhibition in AKAP-Lbc-RhoA signaling complex.
Khan A; Munir M; Aiman S; Wadood A; Khan AU
Comput Biol Chem; 2017 Apr; 67():84-91. PubMed ID: 28063348
[TBL] [Abstract][Full Text] [Related]
13. Gastrokine 1 inhibits gastric cancer cell migration and invasion by downregulating RhoA expression.
Yoon JH; Choi WS; Kim O; Choi BJ; Nam SW; Lee JY; Park WS
Gastric Cancer; 2017 Mar; 20(2):274-285. PubMed ID: 27250838
[TBL] [Abstract][Full Text] [Related]
14. RhoA regulates G1-S progression of gastric cancer cells by modulation of multiple INK4 family tumor suppressors.
Zhang S; Tang Q; Xu F; Xue Y; Zhen Z; Deng Y; Liu M; Chen J; Liu S; Qiu M; Liao Z; Li Z; Luo D; Shi F; Zheng Y; Bi F
Mol Cancer Res; 2009 Apr; 7(4):570-80. PubMed ID: 19372585
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-31 inhibits RhoA-mediated tumor invasion and chemotherapy resistance in MKN-45 gastric adenocarcinoma cells.
Korourian A; Roudi R; Shariftabrizi A; Madjd Z
Exp Biol Med (Maywood); 2017 Dec; 242(18):1842-1847. PubMed ID: 28836853
[TBL] [Abstract][Full Text] [Related]
16. IL-6 induces AGS gastric cancer cell invasion via activation of the c-Src/RhoA/ROCK signaling pathway.
Lin MT; Lin BR; Chang CC; Chu CY; Su HJ; Chen ST; Jeng YM; Kuo ML
Int J Cancer; 2007 Jun; 120(12):2600-8. PubMed ID: 17304514
[TBL] [Abstract][Full Text] [Related]
17. Cucurbitacin B inhibits gastric cancer progression by suppressing STAT3 activity.
Xu J; Chen Y; Yang R; Zhou T; Ke W; Si Y; Yang S; Zhang T; Liu X; Zhang L; Xiang K; Guo Y; Liu Y
Arch Biochem Biophys; 2020 May; 684():108314. PubMed ID: 32088220
[TBL] [Abstract][Full Text] [Related]
18. Zoledronic Acid Inhibits the RhoA-mediated Amoeboid Motility of Prostate Cancer Cells.
Pietrovito L; Comito G; Parri M; Giannoni E; Chiarugi P; Taddei ML
Curr Cancer Drug Targets; 2019; 19(10):807-816. PubMed ID: 30648509
[TBL] [Abstract][Full Text] [Related]
19. Clinically relevant concentration of sevoflurane suppresses cervical cancer growth and migration through targeting multiple oncogenic pathways.
Ding J; Zhang L; Zeng S; Feng T
Biochem Biophys Res Commun; 2019 Jul; 514(4):1179-1184. PubMed ID: 31103261
[TBL] [Abstract][Full Text] [Related]
20. Fbxw7 regulates tumor apoptosis, growth arrest and the epithelial-to-mesenchymal transition in part through the RhoA signaling pathway in gastric cancer.
Li H; Wang Z; Zhang W; Qian K; Xu W; Zhang S
Cancer Lett; 2016 Jan; 370(1):39-55. PubMed ID: 26458995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
